191 related articles for article (PubMed ID: 11606507)
1. Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas.
Rooman I; Lardon J; Flamez D; Schuit F; Bouwens L
Gastroenterology; 2001 Oct; 121(4):940-9. PubMed ID: 11606507
[TBL] [Abstract][Full Text] [Related]
2. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors.
Singh P; Owlia A; Espeijo R; Dai B
J Biol Chem; 1995 Apr; 270(15):8429-38. PubMed ID: 7721737
[TBL] [Abstract][Full Text] [Related]
3. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
4. Transient agonist-induced regulation of the cholecystokinin-A and cholecystokinin-B receptor mRNA levels in rat pancreatic acinar AR42J cells.
Günther R; Carstens OC; Schmidt WE; Fölsch UR
Pancreatology; 2003; 3(1):47-54. PubMed ID: 12649564
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
[TBL] [Abstract][Full Text] [Related]
6. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
Ohlsson B; Fredäng N; Axelson J
Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070
[TBL] [Abstract][Full Text] [Related]
7. Identification of gastrin as a growth peptide in human pancreatic cancer.
Smith JP; Fantaskey AP; Liu G; Zagon IS
Am J Physiol; 1995 Jan; 268(1 Pt 2):R135-41. PubMed ID: 7840313
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells.
Dabrowski A; Detjen KM; Logsdon CD; Williams JA
Digestion; 1997; 58(4):361-7. PubMed ID: 9324163
[TBL] [Abstract][Full Text] [Related]
9. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
Zavros Y; Shulkes A
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
Ding XQ; Chen D; Håkanson R
Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms for the growth factor action of gastrin.
Todisco A; Takeuchi Y; Urumov A; Yamada J; Stepan VM; Yamada T
Am J Physiol; 1997 Oct; 273(4):G891-8. PubMed ID: 9357832
[TBL] [Abstract][Full Text] [Related]
13. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma.
Smith JP; Shih AH; Wotring MG; McLaughlin PJ; Zagon IS
Int J Oncol; 1998 Feb; 12(2):411-9. PubMed ID: 9458369
[TBL] [Abstract][Full Text] [Related]
15. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat.
Kawabata S; Kanayama S; Shinomura Y; Miyazaki Y; Imamura I; Moriwaki K; Wada H; Tarui S
Regul Pept; 1991 Jul; 35(1):1-10. PubMed ID: 1924892
[TBL] [Abstract][Full Text] [Related]
16. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
18. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV
Digestion; 1991; 49(2):97-105. PubMed ID: 1724767
[TBL] [Abstract][Full Text] [Related]
19. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
Terashima H; Debas HT; Bunnett NW
Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370
[TBL] [Abstract][Full Text] [Related]
20. A new CCK-B/gastrin receptor antagonist acts as an agonist on the rat pancreas.
Koop I; Eissele R; Richter S; Patberg H; Meyer F; Mössner J; Arnold R; Koop H
Int J Pancreatol; 1994 Jun; 15(3):215-22. PubMed ID: 7523549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
